Bullisch
$192.30
Szenariopreis
$108.370
+2.167 (+2.00%)Zum Schluss
Paychex, Inc. is a human capital management (HCM) company. The Company is engaged in delivering a full suite of technology and advisory solutions in human resources, employee benefit solutions, insurance, and payroll for clients and their employees in the United States and parts of Europe. It offers integrated HCM solutions covering the employee life cycle for businesses and their employees. It supports its clients through its proprietary Paychex Flex platform, Paycor and the Company's SurePayroll software as a service (SaaS)-based solution. Its services include payroll services, time and attendance, employee benefits, human resources (HR), professional employer organization, talent management, business insurance, and payment processing. Its talent management includes recruiting, hiring and onboarding, performance management, learning and development, compensation management, employee engagement and recognition, employee benefits, among others.
Paychex Inc is currently trading at $103.98, which is below the analyst price target range of $110 to $121.17, indicating potential upside. However, the recent downgrade in growth expectations and a 12.83% decline in stock price over the past week suggest caution. The RSI of 55.69 indicates a neutral momentum, while the forward P/E of 17.54 suggests the stock is reasonably valued. The main risk is the company's recent revenue growth slowdown, which is only 6% year-over-year compared to 17% previously, raising concerns about future performance.
Baird
$110
2026-09-28
Baird
2026-09-28
Kursziel
$110
UBS
$115
2026-09-24
UBS
2026-09-24
Kursziel
$115
Stifel
$112
2026-09-24
Stifel
2026-09-24
Kursziel
$112
BMO Capital
$113
2026-09-24
BMO Capital
2026-09-24
Kursziel
$113
JPMorgan
$115
2026-09-23
JPMorgan
2026-09-23
Kursziel
$115
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Paychex Declares Quarterly Cash Dividend

IRS Appoints New Advisor to Advance Trump Accounts

Paychex Reports Strong Q1 2027 Results Amid Stock Decline

JP Morgan Upgrades Paychex Outlook to Neutral

Paychex Q1 Fiscal 2027 Earnings Highlights
Paychex, Inc. is a human capital management (HCM) company. The Company is engaged in delivering a full suite of technology and advisory solutions in human resources, employee benefit solutions, insurance, and payroll for clients and their employees in the United States and parts of Europe. It offers integrated HCM solutions covering the employee life cycle for businesses and their employees. It supports its clients through its proprietary Paychex Flex platform, Paycor and the Company's SurePayroll software as a service (SaaS)-based solution. Its services include payroll services, time and attendance, employee benefits, human resources (HR), professional employer organization, talent management, business insurance, and payment processing. Its talent management includes recruiting, hiring and onboarding, performance management, learning and development, compensation management, employee engagement and recognition, employee benefits, among others. It operates in the Industrials sector (SERVICES-ENGINEERING, ACCOUNTING, RESEARCH, MANAGE industry).
Paychex Inc is currently trading at $103.98, which is below the analyst price target range of $110 to $121.17, indicating potential upside. However, the recent downgrade in growth expectations and a 12.83% decline in stock price over the past week suggest caution. The RSI of 55.69 indicates a neutral momentum, while the forward P/E of 17.54 suggests the stock is reasonably valued. The main risk is the company's recent revenue growth slowdown, which is only 6% year-over-year compared to 17% previously, raising concerns about future performance.
19 analysts cover PAYX: 2 rate it Buy, 14 Hold and 3 Sell. The average price target is 120.55.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.